Key Note: Uveal Melanoma 2020 - Dr Carol L Shields

CATALYST: Series 1. Ocular Melanoma - Risk Factor Assessment - Carol L. Shields, MDПодробнее

Carol L. Shields, MD - Wills Eye ConferenceПодробнее

Metastatic Eye Cancer with Dr Carol Shields" Hope on the Horizon"Подробнее

ASRS Leaders and Legends Interview: Carol L. Shields, MD, FASRSПодробнее

Moderator of the Keynote Lecture of my mentor and World-Renowned Ocular Oncologist Dr.Carol ShieldsПодробнее

Dr. Carol L. Shields - Intraarterial chemotherapy Indications and results in 2022Подробнее

Uveal Melanoma 2022 | C. ShieldsПодробнее

Ocular Tumors! 2020 with "Inner Sight!" Relaxation by Dada J. P. VaswaniПодробнее

Demystifying (finally) Ocular Oncology - Carol ShieldsПодробнее

Trailblazer Dr. Carol ShieldsПодробнее

SESIÓN VIRTUAL CAPÍTULO DE ONCOLOGÍA - DRA. CAROL SHIELDS (USA) - DR. HAREM KREMA (CANADA)Подробнее

GREEK SUBS Carol ShieldsПодробнее

Carol L. Shields, MDПодробнее

Eye Cancer Investigational Drug Trial at Wills Eye HospitalПодробнее

Ocular Melanoma Patient Retreat 2013 - Dr. Carol Shields - "The Game of Uveal Melanoma"Подробнее

Aura Biosciences Prepares for Phase IIa TrialПодробнее

Risk Factors in Uveal MelanomaПодробнее

Catalyst, Series 1: Retinoblastoma - Advances in Intravitreal Chemotherapy - Carol L. Shields, MDПодробнее

PAOOS WEBINAR - CAROL SHIELDS MD (USA) - HAREM KREMA MD (CANADA), JULY 2020.Подробнее

DNA-based analysis identifies risk factor for metastasis of uveal melanomaПодробнее